ReWalk Robotics Ltd (RWLK)

[StockLogistics]

“7:17a ET 9/28/2022 - Benzinga
ReWalk to Submit First Cases for Medicare Coverage Through Medicare Administrative Contractors

ReWalk Robotics Ltd. (Nasdaq: RWLK) is announcing that the Company will begin submitting Medicare cases following CMS's September 26, 2022, announcement affirming that the MACs have discretion to cover and reimburse for the ReWalk exoskeleton. ReWalk Robotics is actively engaged with CMS in its commitment to evaluate complex advanced technologies like exoskeletons.

This is the latest step in ReWalk's efforts to expand access to the Company's exoskeletons for Medicare beneficiaries with SCI. Studies have shown that the ability to ambulate with an exoskeleton has a profound and beneficial impact on health outcomes for individuals with SCI, including through improved mental health, increased gastrointestinal (GI) function and other improvements on the health consequences of a SCI. ReWalk has prioritized working with payers like Medicare to ensure coverage of and access to exoskeleton technologies for individuals who are paralyzed or disabled due to SCI, so they are able to once again experience the health and well-being benefits of functional ambulation.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

Medicare reimbursements are the key